CompletedEarly Phase 1ketamine
The Effects AZD8529 on Ketamine-induced Impairment of Working Memory in Healthy Volunteers
Sponsored by AstraZeneca
NCT ID
NCT00985933
Target Enrollment
20 participants
Start Date
2010-02
Est. Completion
2011-04
About This Study
The purpose of this study is to assess if ketamine will induce, in healthy volunteers, impairment of working memory and if the drug AZD8529 will block the effects of ketamine on working memory as assessed by functional magnetic resonance imaging (fMRI).
Conditions Studied
Interventions
- •AZD8529
- •Placebo to match AZD8529
Eligibility
Age:21 Years - 45 Years
Healthy Volunteers:Yes
View full eligibility criteria
Inclusion Criteria: * Right handed * 12th grade education or equivalent * Able to read and write English as primary language Exclusion Criteria: * History of head injury * Substance abuse or dependence * History of claustrophobia
Study Locations (1)
Research Site
New Haven, Connecticut, United States